New Jersey MedicaidMedicaid · Reimbursement · Provider Notice · NJ · Family Medicine, Internal Medicine, OB-GYN +3 moreHigh impact
Newsletter Vol. 32, No.07
Act
immediately
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
New Jersey Medicaid has clarified reimbursement rules for physician and outpatient-administered drugs, including LARC devices. Providers must now bill their actual drug acquisition cost as the submitted charge, and use modifier 'U8' when billing 340B drugs or LARC devices.
Get alerts when payers change rules like this one
We check New Jersey Medicaid and other payers every day and email you when a change matches your specialty and state.
01Billing team must update procedures to bill actual drug acquisition cost (not AWP or other pricing) as the submitted charge for all physician and outpatient-administered drugs.
02Add modifier 'U8' to all 340B drugs and LARC devices when using HCPCS codes J0120-J9999 and other specified codes.
03Update billing software to reflect 340B acquisition pricing in charge field for 340B inventory drugs.
Summaries are AI-assisted. Always confirm against the original payer notice.
What is PolicyChanges
One workspace for payer rules, prior auth, coding and compliance
Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.